Condition: Cochlear Implant · Hearing Loss · Sponsor: Hearts for Hearing
Cochlear implants are surgically implanted devices which restore the ability to hear to the hearing impaired. Improvements in surgery and electrodes have results in an increased number of adults and children who have residual hearing and can benefit from electric and acoustic hearing in the same ear. This is called Electric Acoustic Stimulation (EAS). Many studies have shown that adult EAS users show significant benefits for speech understanding in noise and spatial hearing tasks as compared to a CI paired only with a contralateral HA. Even though this type of hearing is becoming more common, there is limited research on how it can be beneficial to children with CIs. The benefits of this study are a greater understanding of the participant's speech understanding, binaural processing, and spatial hearing. The results will help audiologists and researcher better understand how cochlear implants work, specifically when using electric and acoustic hearing in the same ear.
This description comes directly from the study's public registry record.
René Gifford, PhD · (405) 548-4300 · rene.gifford@heartsforhearing.org
Jourdan T Holder, AuD, PhD · jourdan.holder@heartsforhearing.org
Always discuss trial participation with your own doctor first.
| Hearts for Hearing | Edmond, Oklahoma, United States | Recruiting |
| Vanderbilt University Medical Center | Nashville, Tennessee, United States | Completed |
| University Of Texas at Austin | Austin, Texas, United States | Recruiting |
| University Of Wisconsin Madison | Madison, Wisconsin, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05923203